Pomalidomide Update

The US Food and Drug Administration (FDA) has cancelled the planned November advisory committee (ODAC) meeting for Celgene's pomalidomide application.  Celgene, in a press release, indicated that the pomalidomide application is continuing, which means that a decision with regard to pomalidomide is still expected on or before February 10, 2013.

A Visit to the Land of Cherry Blossoms Ahead of the Crowds: IMF Japan Patient and Doctor Meetings: July 2012

We have just returned from a series of meetings in Kyoto, Japan: July 6-8, 2012. Kyoto is the site for the IMW (International Myeloma Workshop) meeting in April 2013 so it was especially helpful to have a preview of the city and International Conference Center (ICC) venue. The ICC is a large center and well capable of hosting the IMW 2013 meeting.

Can Cookies Cause Myeloma?

This may sound like a skit from "Saturday Night Live," but unfortunately, the connection is real.  The first thing to emphasize is that, although it is real, further investigation is required before cookies are added to the "do not eat" list. 

10 Steps to Seeking a Second Opinion

Whether or not to seek a second opinion is a key question and a concern for all patients with myeloma.  This 10-step summary attempts to answer the "ifs, whens, and hows" related to seeking a second opinion.  

Shanghai Revisited: An Environment of Hope

A return visit to Asia by the IMF team of me, Susie Novis and Senior Global Analyst Dan Navid this past week was an exhilarating blur of activities that instructed, impressed and touched us deeply.